Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

ACE inhibition after renal transplantation: the effect on persistent left ventricular hypertrophy

Nature Clinical Practice Nephrology volume 4, pages 22–23 (2008)Cite this article

boxed-textPaoletti E et al. (2007) ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. Am J Kidney Dis 50: 133–142

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mancia G et al. (2007) 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105–1187

    Article  CAS  PubMed  Google Scholar 

  2. London GM et al. (1994) Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 90: 2786–2796

    Article  CAS  PubMed  Google Scholar 

  3. Hausberg M et al. (1999) ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 33: 862–868

    Article  PubMed  Google Scholar 

  4. Heinze G et al. (2006) Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17: 889–899

    Article  CAS  PubMed  Google Scholar 

  5. Jafar TH et al. (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139: 244–252

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Medizinischen Klinik und Poliklinik D, Albert-Schweitzer-Strasse 33, Münster 48149, Germany rahn@uni-muenster.de

Authors and Affiliations

  1. KH Rahn is Professor Emeritus at the University of Münster Medical School, Münster, Germany.,

    Karl H Rahn

Authors
  1. Karl H Rahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahn, K. ACE inhibition after renal transplantation: the effect on persistent left ventricular hypertrophy. Nat Rev Nephrol 4, 22–23 (2008). https://doi.org/10.1038/ncpneph0663

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0663

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing